Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanopore Mechanism Allows Single Strand DNA Sequencing

By LabMedica International staff writers
Posted on 09 Apr 2012
A recent paper described dramatic progress in the development of a nanopore mechanism for rapid sequencing of single DNA strands.

The study, which was published in in the March 25, 2012, online edition of the journal Nature Biotechnology, was based on a nanopore structure that had been created by genetic engineering of a protein pore from Mycobacterium smegmatis. More...
The diameter of the pore was such that only a single strand of DNA could pass through. A molecule of DNA polymerase was attached to the nanopore and acted to pull the DNA strand through the pore. The nanopore structure was placed in a membrane surrounded by potassium-chloride solution, with a small voltage applied to create an ion current flowing through the nanopore.

Details presented in the study revealed that the electrical signature produced by the pore changed depending on the type of nucleotide traveling through it. Each type of DNA nucleotide - cytosine, guanine, adenine, and thymine – produced a distinctive signature. The nanopore complex was tested with six different strands of DNA, and results corresponded to the already known DNA sequence of the strands, which had readable regions 42 to 53 nucleotides long.

“There is a clear path to a workable, easily produced sequencing platform,” said senior author Dr. Jens Gundlach, professor of physics at the University of Washington (Seattle, USA). “We augmented a protein nanopore we developed for this purpose with a molecular motor that moves a DNA strand through the pore a nucleotide at a time. The motor pulls the strand through the pore at a manageable speed of tens of milliseconds per nucleotide, which is slow enough to be able to read the current signal.”

“Epigenetic modifications are rather important for things like cancer," said Dr. Gundlach. “Being able to provide DNA sequencing that can identify epigenetic changes is one of the charms of the nanopore sequencing method. With techniques like this, it might get down to a 10-dollar or 15-minute genome project. It is moving fast.”

Related Links:
University of Washington




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.